Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Cancer Pain × Methadone × Clear all

Phase

Phase 3 2 Phase 4 1 Phase 2/3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain 2 Vomiting 1 Sleep Wake Disorders 1 Opioid-Related Disorders 1 Neoplasms 1 Nausea 1 Lymphoma, Follicular 1 Cancer Pain 1 Breakthrough Pain 1

Interventions

Morphine 2 resiniferatoxin 1 Sodium Bicarbonate 1 Propofol 1 Oxcarbazepine 1 Methadone 1 Electroencephalography 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00125294 2017-09-25

Sublingual Methadone for the Management of Cancer Breakthrough Pain

AHS Cancer Control Alberta

Phase 1 Completed

Cancer Pain, Neoplasms, Pain, Breakthrough Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡